Point72 Asset Management
TBIO

Point72 Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Point72 Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-150,900
Closed -$2.49M – 1255
2021
Q1 		$2.49M Buy
150,900
+69,900
+86% +$1.59M 0.01% 702
2020
Q4 		$1.49M Buy
+81,000
New +$1.45M 0.01% 767

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Point72 Asset Management's TBIO Position: Q2 2021 in Review

Point72 Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 150,900 shares — an estimated $2.49M sold.

Point72 Asset Management first reported a position in TBIO in Q4 2020 and held it in 2 quarters. The position peaked at $2.49M in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Point72 Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Point72 Asset Management sold 150,900 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $2.49M.
  • Point72 Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Point72 Asset Management's Translate Bio, Inc. Common Stock position peaked at $2.49M in Q1 2021.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.